AR and diabetes mellitus: Furthermore, aldose reductase (AR) in this pathway contributes to diabetic complications; its overexpression in ApoE knockout mice with diabetes hastens atherosclerosis, whereas pharmacological inhibition of AR alleviates disease progression [78].